Clinical Trial Update: Open Label Use Of RiaStap During Aortic Reconstruction [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating RiaStap for controlling coagulopathic bleeding during aortic reconstruction; the study is completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy

Drugs mentioned

• RiaStap

Snippet

Sponsor: Duke University | Conditions: Coagulopathic Bleeding | Phase 4 | Status: COMPLETED | Results posted: 2014-06-16